Institutional investors purchased a net $9.7 million shares of VICL during the quarter ended June 2015, and now own 35.38% of the total float, a percentage that is typical for companies in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
APO ASSET MANAGEMENT GMBH Bought 150.0 Thousand shares of Vical Inc